Thursday, July 07, 2011 5:58:02 PM
I noticed the same thing, also couldn't find any news anywhere. Weird. NPHC had a rather busy day too, it would appear....the price % increase (33%) is of course rather meaningless (shut up, BE, we don't care what you have to say), but the volume is interesting to say the least.
As far as a "real" stock goes, my HOTT shares soared 15% today, unbelievable....they actually booked a profit this quarter! I was going to dump them as soon as I got back to green, but now that I'm there it makes more sense to hold onto them thru the back to school season, at a minimum. They even pay a divvy, believe it or not...only 7 cents/qtr, but hey, it's better than nothing
The last two weeks have been very, very good for my IRA, one more day like today and I'll back at my peak value or higher, this time with a different mix of stocks/funds, despite my XCHO/ARNA (paper) losses, which makes it even more impressive - ARNA could still be a huge winner over time, especially if the CRO report we're waiting on refutes the nutty rat tumor statistical BS the FDA pulled on them at their Lorcaserin AdCom - it's fully expected to do so, despite what some nutjob on TheStreet.com claims.
But picking up GLNG earlier this year might have been the best stock pick I've ever made, it's up more than 107% in less than 5 months, whew, what a ride!
As far as a "real" stock goes, my HOTT shares soared 15% today, unbelievable....they actually booked a profit this quarter! I was going to dump them as soon as I got back to green, but now that I'm there it makes more sense to hold onto them thru the back to school season, at a minimum. They even pay a divvy, believe it or not...only 7 cents/qtr, but hey, it's better than nothing
The last two weeks have been very, very good for my IRA, one more day like today and I'll back at my peak value or higher, this time with a different mix of stocks/funds, despite my XCHO/ARNA (paper) losses, which makes it even more impressive - ARNA could still be a huge winner over time, especially if the CRO report we're waiting on refutes the nutty rat tumor statistical BS the FDA pulled on them at their Lorcaserin AdCom - it's fully expected to do so, despite what some nutjob on TheStreet.com claims.
But picking up GLNG earlier this year might have been the best stock pick I've ever made, it's up more than 107% in less than 5 months, whew, what a ride!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
